NCT01673373View on ClinicalTrials.gov

Renal Stent Placement for the Treatment of Renal Artery Stenosis in Patients With Resistant Hypertension

NACompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

October 23, 2012

Primary Completion Date

June 27, 2018

Study Completion Date

October 26, 2020

Conditions
Renal Artery StenosisHypertension, Renovascular
Interventions
DEVICE

iCAST™ Rx Stent System

All enrolled subjects will undergo primary stenting of the target lesion(s) by placement of the iCAST™ RX Stent System.

Trial Locations (12)

27610

NC Heart and Vascular Research, Raleigh

28204

Mid Carolina Cardiology, Charlotte

33756

Clearwater Cardiovascular and Interventional Consultants, Clearwater

37660

Wellmont CVA Heart Institute, Kingsport

37934

Tennova Healthcare - Turkey Creek Medical Center, Knoxville

43214

OhioHealth Research Institute, Columbus

48073

Beaumont Health Systems, Royal Oak

60563

Advocate Health and Hospitals Corporation, Naperville

80538

Medical Center of the Rockies, Loveland

94538

Mission Cardiovascular Research Institute, Fremont

02114

Massachusetts General Hospital, Boston

07666

Holy Name Medical Center, Teaneck

Sponsors
All Listed Sponsors
lead

Atrium Medical Corporation

INDUSTRY

NCT01673373 - Renal Stent Placement for the Treatment of Renal Artery Stenosis in Patients With Resistant Hypertension | Biotech Hunter | Biotech Hunter